Cargando…
Blood-based identification of non-responders to anti-TNF therapy in rheumatoid arthritis
BACKGROUND: Faced with an increasing number of choices for biologic therapies, rheumatologists have a critical need for better tools to inform rheumatoid arthritis (RA) disease management. The ability to identify patients who are unlikely to respond to first-line biologic anti-TNF therapies prior to...
Autores principales: | Thomson, Ty M., Lescarbeau, Reynald M., Drubin, David A., Laifenfeld, Daphna, de Graaf, David, Fryburg, David A., Littman, Bruce, Deehan, Renée, Van Hooser, Aaron |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4455917/ https://www.ncbi.nlm.nih.gov/pubmed/26036272 http://dx.doi.org/10.1186/s12920-015-0100-6 |
Ejemplares similares
-
Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling
por: Lescarbeau, Reynald M, et al.
Publicado: (2014) -
In Vitro Model of Metastasis to Bone Marrow Mediates Prostate Cancer Castration Resistant Growth through Paracrine and Extracellular Matrix Factors
por: Lescarbeau, Reynald M., et al.
Publicado: (2012) -
Discontinuation rates of biologics in patients with rheumatoid arthritis: are TNF inhibitors different from non-TNF inhibitors?
por: Ramiro, Sofia, et al.
Publicado: (2015) -
Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy
por: McGeough, Cathy M., et al.
Publicado: (2011) -
Tumor Necrosis Factor (TNF) Bioactivity at the Site of an Acute Cell-Mediated Immune Response Is Preserved in Rheumatoid Arthritis Patients Responding to Anti-TNF Therapy
por: Byng-Maddick, Rachel, et al.
Publicado: (2017)